This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy International Europe

Savings Deadline Expires In:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
2-4 December 2024
Convention Centre DublinDublin, Ireland

Pranav Puri, PhD
Head Process Development at VectorY
Speaker

Profile

Pranav Puri Head of PD at VectorY, Amsterdam, Netherlands, obtained his PhD in the fileld of Biochemistry at the University of Groningen, The Netherlands. Currently, he leads process development activities at VectorY to ensure availability of robust and well-yielding platform technologies and thereby enabling the progress of VectorY’s candidate novel therapeutics (AAV-based vectorized antibodies) from early R&D to clinic. He has over 8 years of industry experience in the field of viral and viral vector manufacturing and process development.

Agenda Sessions

  • Insect cells as a factory for production of Vectorised antibodies

    11:30